I. Comino-Méndez

发表

High frequency and founder effect of the CYP3A4*20 loss-of-function allele in the Spanish population classifies CYP3A4 as a polymorphic enzyme

M. Ingelman-Sundberg, Á. Carracedo, Ahmed Rebai, 2014, The Pharmacogenomics Journal.

Assessment of Molecular Relapse Detection in Early-Stage Breast Cancer.

M. Dowsett, S. Johnston, I. Smith, 2019, JAMA oncology.

MAX Mutations Cause Hereditary and Sporadic Pheochromocytoma and Paraganglioma

M. Urioste, P. Chanson, M. Blok, 2012, Clinical Cancer Research.

Gain-of-function mutations in DNMT3A in patients with paraganglioma

B. Crespo-Facorro, G. Pita, M. Alonso, 2018, Genetics in Medicine.

Tumoral EPAS1 (HIF2A) mutations explain sporadic pheochromocytoma and paraganglioma in the absence of erythrocytosis.

G. Pita, M. Alonso, L. Inglada-Perez, 2013, Human molecular genetics.

Influence of RET mutations on the expression of tyrosine kinases in medullary thyroid carcinoma.

L. Inglada-Perez, R. Letón, C. Rodríguez-Antona, 2013, Endocrine-related cancer.

Whole-exome sequencing identifies MDH2 as a new familial paraganglioma gene.

Juan F. García, F. Setién, M. Urioste, 2015, Journal of the National Cancer Institute.

VEGF, VEGFR3, and PDGFRB protein expression is influenced by RAS mutations in medullary thyroid carcinoma.

Juan F. García, L. Inglada-Perez, R. Letón, 2014, Thyroid : official journal of the American Thyroid Association.

Unveiling the Potential of Liquid Biopsy in HER2-Positive Breast Cancer Management

E. Alba, I. Comino-Méndez, A. Godoy-Ortiz, 2022, Cancers.

Targeted Exome Sequencing of Krebs Cycle Genes Reveals Candidate Cancer–Predisposing Mutations in Pheochromocytomas and Paragangliomas

M. Esteller, G. Pita, L. Maestre, 2017, Clinical Cancer Research.

Running title : β-tubulin VI variability and paclitaxel toxicity 1 Title : Hematologi β-tubulin VI isoform exhibits genetic variability that influences paclitaxel toxicity

L. Inglada-Perez, R. Letón, C. Rodríguez-Antona, 2012 .

Hematologic β-tubulin VI isoform exhibits genetic variability that influences paclitaxel toxicity.

L. Inglada-Perez, R. Letón, C. Rodríguez-Antona, 2012, Cancer research.

ATRX driver mutation in a composite malignant pheochromocytoma.

M. Blasco, R. Letón, R. Tonda, 2016, Cancer genetics.

Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma

J. Benítez, A. González-Neira, G. Pita, 2011, Nature Genetics.

TITLE: Targeted exome sequencing of Krebs cycle genes reveals candidate cancer predisposing mutations in pheochromocytomas and paragangliomas

M. Esteller, G. Pita, L. Maestre, 2017 .

Recommendations for somatic and germline genetic testing of single pheochromocytoma and paraganglioma based on findings from a series of 329 patients

E. Korpershoek, X. Matías-Guiu, A. Patiño-García, 2015, Journal of Medical Genetics.

Genetics of pheochromocytoma and paraganglioma in Spanish pediatric patients.

M. Marazuela, L. Inglada-Perez, R. Letón, 2013, Endocrine-related cancer.

Development of a Novel NGS Methodology for Ultrasensitive Circulating Tumor DNA Detection as a Tool for Early-Stage Breast Cancer Diagnosis

A. Lluch, E. Alba, M. Queipo-Ortuño, 2022, International journal of molecular sciences.

Breast and Gut Microbiota Action Mechanisms in Breast Cancer Pathogenesis and Treatment

E. Alba, L. Sánchez-Alcoholado, M. Queipo-Ortuño, 2020, Cancers.

Challenges and achievements of liquid biopsy technologies employed in early breast cancer

E. Alba, M. Queipo-Ortuño, I. Comino-Méndez, 2020, EBioMedicine.

Integrative analysis of miRNA and mRNA expression profiles in pheochromocytoma and paraganglioma identifies genotype-specific markers and potentially regulated pathways.

Diego Megias, Javier Muñoz, Agnieszka Maliszewska, 2013, Endocrine-related cancer.

Diverse BRCA1 and BRCA2 Reversion Mutations in Circulating Cell-Free DNA of Therapy-Resistant Breast or Ovarian Cancer

L. Borsu, J. Reis-Filho, L. Norton, 2017, Clinical Cancer Research.

Detection of the first gross CDC73 germline deletion in an HPT‐JT syndrome family

J. Cigudosa, J. Suela, L. Sánchez, 2011, Genes, chromosomes & cancer.

Regulatory Polymorphisms in β-Tubulin IIa Are Associated with Paclitaxel-Induced Peripheral Neuropathy

M. Dolan, H. Gréen, E. Åvall-Lundqvist, 2012, Clinical Cancer Research.

Title: Regulatory polymorphisms in β -tubulin IIa are associated with paclitaxel-induced peripheral neuropathy

M. Dolan, H. Gréen, E. Åvall-Lundqvist, 2012 .

DNA Methylation Profiling in Pheochromocytoma and Paraganglioma Reveals Diagnostic and Prognostic Markers

M. Fraga, E. Letouzé, E. Korpershoek, 2015, Clinical Cancer Research.

Gain-of-function mutations in DNMT3A in patients with paraganglioma

B. Crespo-Facorro, G. Pita, M. Alonso, 2018, Genetics in Medicine.

Functional and in silico assessment of MAX variants of unknown significance

Juan F. García, G. Montoya, L. Inglada-Perez, 2015, Journal of Molecular Medicine.

Role of MDH2 pathogenic variant in pheochromocytoma and paraganglioma patients

T. Pons, E. Korpershoek, F. Beuschlein, 2018, Genetics in Medicine.

Predicting Relapse with Circulating Tumor DNA Analysis in Lung Cancer.

N. Turner, I. Comino-Méndez, 2017, Cancer discovery.